Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
IO Biotech
company
About
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €11M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Dec 23, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. The pipeline of first-in-class immune modulating anti-cancer therapies is developed by a unique technology platform, T-win®, enabling the activation of T cells that are specific for immune-suppressive molecules. IO Biotech has a proven track record of progressing preclinical and clinical compounds. The two lead compounds targeting IDO and PD-L1 are in clinical development and several pipeline compounds are in pre-clinical phase.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€138M
IO Biotech has raised a total of
€138M
in funding over 2 rounds. Their latest funding was raised on
Jan 13, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 13, 2021 | Series B | €127M | 1 | — | — | Detail |
| Jan 5, 2016 | Series A | €11M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
IO Biotech is funded by 2 investors.
Lundbeckfonden Emerge
and Novo Nordisk
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lundbeckfonden Emerge
|
— | Series B |
Novo Nordisk
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
